Ebers GCEnvironmental factors and multiple sclerosis. Lancet Neurol2008; 7: 268-277.
2.
Ramagopalan SV, Dyment DA, Ebers GCGenetic epidemiology: the use of old and new tools for multiple sclerosis. Trends Neurosci2008; 31: 645-652.
3.
Thacker EL, Mirzaei F., Ascherio A.Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis . Ann Neurol2006; 59: 499-503.
4.
Ramagopalan SV , Valdar W., Dyment DA, et al. Association of infectious mononucleosis with multiple sclerosis. A population-based study. Neuroepidemiology2009; 32: 257-262.
5.
Nielsen TR, Rostgaard K., Askling J., et al. Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis. Mult Scler2009; 15: 431-436.
6.
De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A.Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology2008; 70: 1113-1118.
7.
Sadovnick AD, Risch NJ, Ebers GCCanadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method. Canadian Collaborative Study Group. Can J Neurol Sci1998; 25: 216-221.
8.
Ramagopalan SV, Morris AP, Dyment DA, et al. The inheritance of resistance alleles in multiple sclerosis. PLoS Genet2007; 3: e150.
